[Treatment of purulent meningitis using Sigmamycin].
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000401:mortality; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008585:Meningitis, Meningococcal / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D009827:Oleandomycin / Q000009:adverse effects / Q000627:therapeutic use*; D013492:Suppuration; D013752:Tetracycline / Q000009:adverse effects / Q000627:therapeutic use*
D013752:Tetracycline; D009827:Oleandomycin
Behandlung der Meningitis purulenta mit Sigmanycin.